Form 4: Vaxart CFO Phillip E. Lee Reports Tax Withholding Transaction

Phillip E. Lee, CFO of Vaxart, Inc., reports the withholding of shares to cover income tax obligations related to vested RSUs.

Summary

• Phillip E. Lee, the Chief Financial Officer of Vaxart, Inc., filed a Form 4 on March 20, 2025, reporting a transaction that occurred on March 18, 2025.
• The transaction involved the withholding of 8,050 shares of common stock to satisfy income tax obligations related to the net settlement of Restricted Stock Units (RSUs) that vested on March 18, 2025.
• The shares were withheld by the issuer at a price of $0.5702 per share.
• Following the transaction, Lee directly owns 225,619 shares of Vaxart common stock.
• Lee has granted power of attorney to Steven Lo, Edward B. Berg, and Faith L. Charles to execute and file Forms 3, 4, and 5 on his behalf.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine transaction related to tax obligations and RSU vesting.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a standard tax withholding procedure.

Key Dates

Keywords

Form 4, Vaxart, Phillip E. Lee, CFO, Stock withholding, RSUs, Tax obligations, Beneficial ownership, Power of attorney, VXRT